Terms: = Head and neck cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Diagnosis
16 results:
1. SEPT9, H4C6, and RASSF1A methylation in nasopharyngeal swabs: A reflection of potential minimally invasive biomarkers for early screening of nasopharyngeal cancer.
Qian T; Zhou Z; Zhang Q; Liou YL; Zhou H
Medicine (Baltimore); 2023 Dec; 102(50):e36583. PubMed ID: 38115290
[TBL] [Abstract] [Full Text] [Related]
2. Mortality Risk factors and sox2 and mTOR expression in Patients with Esophageal cancer.
Yu G; Yuexin Y; Yin L; Yiyin Z; Mei K; Liyang Z; Lei X; Fan W
Cell Mol Biol (Noisy-le-grand); 2022 Jan; 67(4):346-357. PubMed ID: 35809269
[TBL] [Abstract] [Full Text] [Related]
3. Stem signatures associating sox2 antibody helps to define diagnosis and prognosis prediction with esophageal cancer.
Peng ZY; Wang QS; Li K; Chen SS; Li X; Xiao GD; Tang SC; Ren H; Wang Z; Sun X
Ann Med; 2022 Dec; 54(1):921-932. PubMed ID: 35382656
[TBL] [Abstract] [Full Text] [Related]
4. CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome.
Patil S
Curr Issues Mol Biol; 2021 Jun; 43(1):423-433. PubMed ID: 34205649
[TBL] [Abstract] [Full Text] [Related]
5. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/sox2-mediated stemness.
Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
[TBL] [Abstract] [Full Text] [Related]
6. Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma.
Ye Z; Fang J; Wang Z; Wang L; Li B; Liu T; Wang Y; Hua J; Wang F; Fu Z
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32662828
[TBL] [Abstract] [Full Text] [Related]
7. Stem cell markers in oral and oropharyngeal squamous cell carcinomas in relation to the site of origin and HPV infection: clinical implications.
Rizzo D; Graziani C; Gallus R; Zannoni GF; Lucchetti D; Parrilla C; Boninsegna A; Galli J; Paludetti G; Bussu F; Sgambato A
Acta Otorhinolaryngol Ital; 2020 Apr; 40(2):90-98. PubMed ID: 32469002
[TBL] [Abstract] [Full Text] [Related]
8. A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma.
Hussein AA; Forouzanfar T; Bloemena E; de Visscher J; Brakenhoff RH; Leemans CR; Helder MN
Br J Cancer; 2018 Sep; 119(6):724-736. PubMed ID: 30131545
[TBL] [Abstract] [Full Text] [Related]
9. Salivary Gland cancer Patient-Derived Xenografts Enable Characterization of cancer Stem Cells and New Gene Events Associated with Tumor Progression.
Keysar SB; Eagles JR; Miller B; Jackson BC; Chowdhury FN; Reisinger J; Chimed TS; Le PN; Morton JJ; Somerset HL; Varella-Garcia M; Tan AC; Song JI; Bowles DW; Reyland ME; Jimeno A
Clin Cancer Res; 2018 Jun; 24(12):2935-2943. PubMed ID: 29555661
[No Abstract] [Full Text] [Related]
10. Transcriptional suppression of microRNA-27a contributes to laryngeal cancer differentiation via GSK-3β-involved Wnt/β-catenin pathway.
Chen S; Sun YY; Zhang ZX; Li YH; Xu ZM; Fu WN
Oncotarget; 2017 Feb; 8(9):14708-14718. PubMed ID: 28122350
[TBL] [Abstract] [Full Text] [Related]
11. Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control study.
van Olphen SH; Ten Kate FJC; Doukas M; Kastelein F; Steyerberg EW; Stoop HA; Spaander MC; Looijenga LHJ; Bruno MJ; Biermann K;
Medicine (Baltimore); 2016 Nov; 95(47):e5402. PubMed ID: 27893678
[TBL] [Abstract] [Full Text] [Related]
12. A Limited Immunohistochemical Panel to Distinguish Basal Cell Carcinoma of Cutaneous Origin From Basaloid Squamous Cell Carcinoma of the head and neck.
Villada G; Kryvenko ON; Campuzano-Zuluaga G; Kovacs C; Chapman J; Gomez-Fernandez C
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):126-131. PubMed ID: 27438511
[TBL] [Abstract] [Full Text] [Related]
13. sox2 as a novel marker to predict neoplastic progression in Barrett's esophagus.
van Olphen S; Biermann K; Spaander MC; Kastelein F; Steyerberg EW; Stoop HA; Bruno MJ; Looijenga LH
Am J Gastroenterol; 2015 Oct; 110(10):1420-8. PubMed ID: 26323187
[TBL] [Abstract] [Full Text] [Related]
14. Evaluating the miR-302b and miR-145 expression in formalin-fixed paraffin-embedded samples of esophageal squamous cell carcinoma.
Tabrizi M; Khalili M; Vasei M; Nouraei N; Mansour Samaei N; Khavanin A; Khajehei M; Mowla SJ
Arch Iran Med; 2015 Mar; 18(3):173-8. PubMed ID: 25773691
[TBL] [Abstract] [Full Text] [Related]
15. sox2 expression in gastrointestinal cancers of Iranian patients.
Rassouli FB; Matin MM; Bahrami AR; Ghaffarzadegan K; Sisakhtnezhad S; Cheshomi H; Abbasi F
Int J Biol Markers; 2015 Jul; 30(3):e315-20. PubMed ID: 25704506
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping.
DiMaio MA; Kwok S; Montgomery KD; Lowe AW; Pai RK
Hum Pathol; 2012 Nov; 43(11):1799-807. PubMed ID: 22748473
[TBL] [Abstract] [Full Text] [Related]
